Platinum-(IV)-derivative satraplatin induced G(2)/M cell cycle perturbation via p53-p21(waf1/cip1)-independent pathway in human colorectal cancer cells

AIM: Platinum-(IV)-derivative satraplatin represents a new generation of orally available anti-cancer drugs that are under development for the treatment of several cancers. Understanding the mechanisms of cell cycle modulation and apoptosis is necessary to define the mode of action of satraplatin. I...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Kalimutho, Murugan, Minutolo, Antonella, Grelli, Sandro, Federici, Giorgio, Bernardini, Sergio
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2011
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4002728/
https://ncbi.nlm.nih.gov/pubmed/21927014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2011.107
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller